ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Yehia Hashad Will Join Bausch + Lomb as EVP of R&D and CMO
January 21, 2022Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") has announced that Dr. Yehia Hashad will join Bausch + Lomb Corporation ("Bausch + Lomb") as executive vice president... -
FDA Approves Bausch + Lomb Alaway Preservative Free Ophthalmic Solution
October 09, 2020Bausch Health, Bausch + Lomb, and Eton Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved Alaway® Preservative Free (ketotifen fumarate) ophthalmic solution, 0.035%, antihistamine eye drops (EM-100) ... -
Bausch + Lomb Announces FDA Approval of LOTEMAX SM 0.38%
February 27, 2019Bausch + Lomb announced the U.S. Food and Drug Administration (FDA) has approved LOTEMAX SM (loteprednol etabonate ophthalmic gel) 0.38%...
Pharma Sources Insight January 2025
